Drug intelligence / Profile preview

phaseolus vulgaris extract

Development stage
Unknown
Lead developer
Indena
Modality
Small Molecules
Administration
Oral
01

Overview

Phaseolus vulgaris extract is a dietary supplement derived from the common bean (Phaseolus vulgaris), most often from white kidney beans. The primary mechanism of action is inhibition of alpha-amylase in the gastrointestinal tract. By blocking this enzyme’s activity, the extract reduces or delays the digestion and absorption of complex carbohydrates into simple sugars. This leads to decreased caloric intake from carbohydrates and may help promote weight loss and reduce body fat mass[2][4][5][8]. Clinical studies have shown that regular intake can result in significant reductions in body weight and fat percentage compared to placebo[4]. The product is typically standardized for its alpha-amylase inhibitor content (such as phaseolamin) and may also contain phytohemagglutinin[5]. It is marketed primarily for weight management.

Brand names
BeanblockPhase 2Phase2Phase-2
Other names
white kidney bean extractcannellini bean extractlobia extractextrait de haricot blancextrakt aus weißen Kidneybohnenestratto di fagiolo biancoextrato de feijão brancoextracto de frijol blanco
02

Targets

AMY (Pancreatic alpha-amylase)

Beyond the preview

Go deeper on phaseolus vulgaris extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phaseolus vulgaris extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call